CRISPR Therapeutics AG

SecurityCRSP / CRISPR Therapeutics AG
InstitutionIFP Advisors, Inc
Latest Disclosed Ownership1,581 shares
Latest Disclosed Value $ 75,208
IFP Advisors, Inc reports 26.48% increase in ownership of CRSP / CRISPR Therapeutics AG

On April 13, 2026 - IFP Advisors, Inc filed a 13F-HR form disclosing ownership of 1,581 shares of CRISPR Therapeutics AG (US:CRSP) valued at $75,208 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 6, 2026 disclosing 1,250 shares of CRISPR Therapeutics AG. This represents a change in shares of 26.48% during the quarter. The current value of the position is $82,338 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-13 2026-03-31 13F CRISPR THERAPEUTICS cs H17182108 1,581 331 26.48 75 15.38 0.0016
2026-02-06 2025-12-31 13F CRISPR THERAPEUTICS cs H17182108 1,250 288 29.94 66 4.84 0.0015
2026-02-06 2025-09-30 13F/A-1 CRISPR THERAPEUTICS cs H17182108 962 46 5.02 62 40.91 0.0016
2025-12-02 2025-09-30 13F CRISPR THERAPEUTICS cs H17182108 959 43 63 0.0016
2025-07-24 2025-06-30 13F CRISPR THERAPEUTICS cs H17182108 916 181 24.63 45 76.00 0.0013
2025-05-05 2025-03-31 13F CRISPR THERAPEUTICS cs H17182108 735 160 27.83 25 13.64 0.0008
2025-02-04 2024-12-31 13F CRISPR THERAPEUTICS cs H17182108 575 348 153.30 23 120.00 0.0007
2025-02-04 2024-09-30 13F CRISPR THERAPEUTICS cs H17182108 227 52 29.71 11 11.11 0.0004
2024-07-30 2024-06-30 13F CRISPR THERAPEUTICS cs H17182108 175 0 0.00 9 -18.18 0.0004
2024-07-30 2024-03-31 13F CRISPR THERAPEUTICS cs H17182108 175 75 75.00 12 83.33 0.0005
2024-01-09 2023-12-31 13F CRISPR THERAPEUTICS cs H17182108 100 -217 -68.45 6 -57.14 0.0003
2023-10-12 2023-09-30 13F CRISPR THERAPEUTICS cs H17182108 317 -82 -20.55 14 -36.36 0.0006
2023-08-14 2023-06-30 13F/A-1 CRISPR THERAPEUTICS cs H17182108 399 -6 -1.48 22 -18.52 0.0009
2023-08-04 2023-06-30 13F CRISPR THERAPEUTICS cs H17182108 399 -6 27 0.0012
2023-04-18 2023-03-31 13F CRISPR THERAPEUTICS cs H17182108 405 -371 -47.81 27 0.0012
2023-02-07 2022-12-31 13F CRISPR THERAPEUTICS cs H17182108 776 -322 -29.33 0 -100.00 0.0018
2022-11-08 2022-09-30 13F CRISPR THERAPEUTICS cs H17182108 1,098 -83 -7.03 88 -4.35 0.0023
2022-09-06 2022-06-30 13F/A-1 CRISPR THERAPEUTICS cs H17182108 1,181 0 0.00 92 0.00 0.0030
2022-09-06 2022-03-31 13F/A-1 CRISPR THERAPEUTICS cs H17182108 1,181 411 53.38 92 58.62 0.0030
2022-08-08 2022-03-31 13F CRISPR THERAPEUTICS AG NAMEN AKT Stock H17182108 812 42 55 0.0011
2022-01-12 2021-12-31 13F CRISPR THERAPEUTICS AG NAMEN AKT Stock H17182108 770 30 4.05 58 -30.12 0.0011
2021-10-06 2021-09-30 13F CRISPR THERAPEUTICS AG NAMEN AKT Stock H17182108 740 -83 -10.09 83 -37.59 0.0017
2021-07-13 2021-06-30 13F CRISPR THERAPEUTICS AG NAMEN AKT Stock H17182108 823 -31 -3.63 133 27.88 0.0028
2021-04-30 2021-03-31 13F CRISPR THERAPEUTICS AG NAMEN AKT Stock H17182108 854 57 7.15 104 -14.05 0.0020
2021-01-25 2020-12-31 13F CRISPR THERAPEUTICS AG NAMEN AKT Stock H17182108 797 -24 -2.92 121 77.94 0.0049
2020-10-29 2020-09-30 13F CRISPR THERAPEUTICS AG NAMEN AKT Stock H17182108 821 190 30.11 68 41.67 0.0041
2020-08-05 2020-06-30 13F CRISPR THERAPEUTICS AG NAMEN AKT Stock H17182108 631 15 2.44 48 77.78 0.0038
2020-05-12 2020-03-31 13F CRISPR THERAPEUTICS AG NAMEN AKT Stock H17182108 616 500 431.03 27 237.50 0.0027
2020-01-17 2019-12-31 13F CRISPR THERAPEUTICS AG NAMEN AKT Stock H17182108 116 -24 -17.14 8 33.33 0.0006
2019-11-07 2019-09-30 13F CRISPR THERAPEUTICS AG NAMEN AKT Stock H17182108 140 100 250.00 6 500.00 0.0004
2019-05-15 2019-03-31 13F CRISPR THERAPEUTICS Stock H17182108 40 -680 -94.44 1 -94.74 0.0001
2019-06-03 2018-12-31 13F/A-10 CRISPR THERAPEUTICS AG NAMEN AKT Stock H17182108 720 15 2.13 19 -38.71 0.0012
2019-01-23 2018-12-31 13F CRISPR THERAPEUTICS AG NAMEN AKT Stock H17182108 720 15 19 0.0012
2019-06-03 2018-09-30 13F/A-9 CRISPR THERAPEUTICS AG NAMEN AKT Stock H17182108 705 -148 -17.35 31 -38.00 0.0013
2018-10-25 2018-09-30 13F CRISPR THERAPEUTICS AG NAMEN AKT Stock H17182108 705 -148 31 0.0013
2019-06-03 2018-06-30 13F/A-8 CRISPR THERAPEUTICS AG NAMEN AKT Stock H17182108 853 453 113.25 50 455.56 0.0021
2018-08-07 2018-06-30 13F CRISPR THERAPEUTICS AG NAMEN AKT Stock H17182108 853 528 50
2019-06-03 2018-03-31 13F/A-7 CRISPR THERAPEUTICS AG NAMEN AKT Stock H17182108 400 0 0.00 9 0.00 0.0004
2018-05-09 2018-03-31 13F CRISPR THERAPEUTICS AG NAMEN AKT Stock H17182108 325 -75 15
2019-06-03 2017-12-31 13F/A-6 CRISPR THERAPEUTICS AG NAMEN AKT Stock H17182108 400 400 900.00 9 800.00 0.0004
2018-01-24 2017-12-31 13F CRISPR THERAPEUTICS AG NAMEN AKT Stock H17182108 400 360 9
2016-08-22 2016-06-30 13F CRISPR THERAPEUTICS Stock H17182108 0 -40 -100.00 0 -100.00
2019-06-03 2016-03-31 13F/A-1 CRISPR THERAPEUTICS Stock H17182108 40 40 1 0.0001
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.